Impedimed Ltd (OTCPK:IPDQF)
$ 0.048 0 (0%) Market Cap: 70.20 Mil Enterprise Value: 54.36 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 0/100

Q2 2020 ImpediMed Ltd Earnings Call Transcript

Jan 21, 2020 / 10:15PM GMT
Release Date Price: $0.106194
Operator

Thank you for standing by, and welcome to the ImpediMed Limited quarterly results investor conference call. (Operator Instructions)

I would now like to hand the conference over to Mr. Richard Carreon, Managing Director and CEO. Please go ahead.

Richard Carreon
ImpediMed Limited - MD, CEO, President & Executive Director

Thank you, Rachel. Welcome, and thank you for joining us today. We're hosting this conference call to discuss our 4C for the financial quarter ending December 31, 2019.

Before I begin, we at ImpediMed would like to convey our deepest sympathies to all of Australia that you continue to battle the destructive fires that have ravaged your beautiful country. The loss of life and the sheer magnitude of the damage is beyond comprehension. Our heartfelt thoughts and prayers go out to you all.

On today's call, I'll be referencing the 4C we lodged earlier this morning, Australian time. Joining me is Cathy Kingsford, our Senior Vice President of Clinical and Regulatory Affairs; and Tim Cruickshank, our Vice President of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot